The antitumor potency of progesterone antagonists is due to their differentiation potential
- 30 September 1992
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3) , 203-210
- https://doi.org/10.1016/0960-0760(92)90209-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Progesterone antagonists block the growth of experimental mammary tumors in G0/G1Breast Cancer Research and Treatment, 1990
- The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell deathJournal of Steroid Biochemistry, 1989
- Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studiesBreast Cancer Research and Treatment, 1989
- Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the ratEuropean Journal of Cancer and Clinical Oncology, 1989
- Analysis of glycoproteins released from benign and malignant human breast: Changes in size and fucosylation with malignancyEuropean Journal of Cancer and Clinical Oncology, 1989
- Helix pomatia and Ulex Europeus lectin binding in human breast carcinomaThe Journal of Pathology, 1987
- THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*Anz Journal of Surgery, 1984
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957